HEADLINES

Pharmaniaga

Pharmaniaga records 3Q net profit of RM101.03 mln

Revenue increased by 16.3% to RM1.03 billion in 3Q from RM885.49 million previously, primarily driven by the increased demand in the concession segment

Auditor casts doubt on Pharmaniaga ability as going concern

As of Dec 31, 2023, the group and company’s current liabilities exceeded their current assets

Pharmaniaga to raise RM654.6 mil in bid to exit PN17 status

Pharmaniaga Bhd has submitted its regularisation plan to Bursa Malaysia Securities Bhd as the company bids to exit its PN17 status.

Pharmaniaga tandatangan perjanjian konsensi dengan KKM selama tujuh tahun

Pharmaniaga Logistics Sdn Bhd (PLSB) iaitu anak syarikat milik penuh Pharmaniaga Berhad (Pharmaniaga) telah mencapai Perjanjian Konsensi (CA) dengan Kementerian Kesihatan (KKM) untuk membekalkan perkhidmatan bekalan perubatan.

Laporan PAC mengenai perolehan ventilator cetus lebih banyak persoalan berbanding jawapan: MMA

Persatuan Perubatan Malaysia (MMA) menegaskan perlu ada akauntabiliti lengkap atas kekurangan dokumentasi dalam perolehan ventilator yang didedahkan oleh Jawatankuasa Kira-kira Wang Negara (PAC), semalam

Popular

National shuttlers demand RM2 million salaries: can BAM keep up financially?

Several top athletes aim for salaries that could outpace even the highest-earning footballers, raising questions about the sustainability of funding within Malaysian sports

Petronas staff to be shown the door to make up losses from Petros deal?

Source claims national O&G firm is expected to see 30% revenue loss once agreed formula for natural gas distribution in Sarawak is implemented

InDrive faces termination for flouting guidelines

It is the second Russian e-hailing app after Maxim to face ban by Land Public Transport Agency